Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Potassium hydrogen carbonate, Sodium alginate may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
ing this medicine. "metabolic acidosis"). Do not take Gaviscon Advance Aniseed flavour Oral Suspension: This medicine contains 1.0 mmol (39.06 mg) of potassium per5 ml.
Se
—-
=
-_–=
fluoroquinolones (types of antibiotics), iron salts, thyroid hormones, chloroquine (a medication used to prevent malaria}, bisphosphonates (a medication used to treat osteoporosis) and estramustine (a medication to treat prostate cancer).
:
Pregnancy and breast-feeding:
| | | | ! | !
You can take this product if you are pregnant or breast-feeding. As with all medicines, the treatment duration should be limited as much as possible. Important information about some of the ingredients of Gaviscon Advance Aniseed flavour Oral Suspension: This product contains methyl (E218) and propyl (E216) para-hydroxybenzoates which may cause allergic reactions (possibly delayed). Driving and using machines: This medicine has no influence on the abilityto drive and use machines.
| |
: | : | |
this medicine,
Check that the cap seal is unbroken before first using this product. Shake well before use. Adults including the elderly and children 12 years and over: 5-10 ml (one to two 5m spoonfuls) after meals and at bedtime. Children under 12 years: Should only be taken on medical advice. If you forget a dose itis not necessaryto double
—-|-
=|
—
ee
Ke
KS
—– – g
Do not refrigerate. much of this product you may feel bloated and experience some Medicines should not be disposed of via wastewater or abdominal discomfort. Itis unlikelyto cause you any harm, but please consult your doctor or pharmacist if this doesn't go away. household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will helpto Hf symptoms persist after7 days consult your doctor. protect the environment. 4, Possible side effects. Like all medicines, this medicine can cause side effects, although 6, Contents of the pack and other information. not everybody gets them. Very rarely (less than 1 in 10,000 patients) Each 10 ml of oral suspension contains 1000 mg sodium alginate and 200 mg potassium hydrogen carbonate as the active there is a chance of an allergic reaction to the ingredients, Symptoms of this may include skin rash, itching, difficulty ingredients, The other ingredients are calcium carbonate, carbomer, methyl (E218) and propyl (E216) breathing, dizziness or swelling of the face, lips, tongue or throat. parahydroxybenzoates, benzyl alcohol (present in fennel flavour}, Uncommonly reported side-effects are diarrhoea, nausea and vorniting (less than 1 in 100 people). If you experience these or any sodium saccharin, sodium hydroxide, aniseed flavour derived other side effects stop taking the product and consult your doctor from fennel and purified water. This product does not contain immediately. If you get any side effects, talkto your doctor, sugar or gluten. This medicine is available in bottles of 80ml, pharmacist or nurse. This includes any possible side effects not 100ml, 125ml, 140ml, 150ml, 180ml, 200ml, 250ml and 300ml. listed in this leaflet. You can also report side effects directly via the Not all pack sizes may be marketed. Yellow Card Scheme at "httpy/www.mhra.gov.uk/yellowcard' or Manufacturer and Product Licence Holder: Reckitt Benckiser Healthcare (UK) Limited, Hull, HU8 7DS, search for MHRA Yellow Card in the Google Play or Apple App Date of preparation: June 2024 Store, By reporting side effects, you can help provide more information on the safety of this medicine. Gaviscon is a trade mark of the Reckitt group. 5, How to store this medicine, Do not use this product after the expiry date (EXP: month/year) Po LLL 0000000 _ /
. fl. What is this medicine and whats it used for? Gaviscon Advance Aniseed flavour Oral Suspension belongsto a group of medicines called 'reflux suppressants'. This product forms a protective layer that floats on top of the stomach contents. This layer prevents reflux and keeps the stomach
–
: | : |
–
–
–40 — Ss
symptoms of heartburn and acid indigestion. It can also be used to This medicine contains 0.525 mg benzyl alcohol in each 5 ml. Benzyl alcohol may cause allergic reactions. relieve the symptoms of conditions such as hiatus hernia (protrusion of muscle through a muscle wall), reflux oesophagitis Ask your doctor or pharmacist for advice if you are pregnant or (inflamed food pipe) and symptoms of hoarseness and other voice breast-feeding. This is because large amounts of benzyl alcohol disorders, sore throat and cough associated with reflux. Itcan can build-up in your body and may cause side effects (called also be taken to control heartburn symptoms which may occur "metabolic acidosis"). when taking, or following withdrawal of, medication to reduce Ask your doctor or pharmacist for advice if you have liver or kidney stomach acid such as Proton Pump Inhibitors (PI's) or H2 disease. This is because large amounts of benzyl alcohol can Antagonists. build-up in your body and may cause side effects (called
Gaviscon Advance Aniseed flavour Oral Suspension comes as oral solution. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Gaviscon Advance Aniseed flavour Oral Suspension is potassium hydrogen carbonate, sodium alginate.
Medicines with the same active substance, strength and form include: Acidex Advance Oral Suspension (Aniseed Flavour), Acidex Advance Oral Suspension (Peppermint Flavour), Gaviscon Advance Peppermint Flavour Oral Suspension (GSL). They are interchangeable only if your prescriber or pharmacist says so.
This leaflet reproduces the patient information leaflet approved for Gaviscon Advance Aniseed flavour Oral Suspension, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
Treatment of symptoms resulting from the reflux of acid, bile and pepsin into the oesophagus such as acid regurgitation, heartburn, indigestion (occurring due to the reflux of stomach contents), for instance, after gastric surgery, as a result of hiatus hernia, during pregnancy, accompanying reflux oesophagitis, including symptoms of laryngopharyngeal reflux such as hoarseness and other voice disorders, sore throats and cough. Can also be used to treat the symptoms of gastro-oesophageal reflux during concomitant treatment with or following withdrawal of acid suppressing therapy.
Adults and children 12 years and over: 5-10ml after meals and at bedtime
Children under 12 years: Should be given only on medical advice
Elderly: No dose modification is required for this age group.
Hepatic Impairment: No dose modification necessary.
Renal Insufficiency: Caution if highly restricted salt diet is necessary (see section 4.4).
This medicinal product is contraindicated in patients with known or suspected hypersensitivity to any of the ingredients, or any of the excipients listed in section 6.1, including methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216) (see section 4.4).
If symptoms do not improve after 7 days, the clinical situation should be reviewed.
This medicinal product contains 57.85 mg sodium per 5 ml, equivalent to 2.9 % of the WHO recommended maximum daily intake for sodium. The maximum daily dose of this product is equivalent to 23.14 % of the WHO recommended maximum daily intake for sodium.
This product is considered high in sodium. This should be particularly taken into account for those on a low salt diet
Potassium: This medicine contains 1.0 mmol (39.06 mg) potassium per 5 ml . To be taken into consideration by patients with reduced kidney function or patients on a controlled potassium diet.
Each 10 ml contains 200 mg (2.0 mmol) of calcium carbonate. Care needs to be taken in treating patients with hypercalcaemia, nephrocalcinosis and recurrent calcium containing renal calculi.
Contains methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216): May cause allergic reactions (possibly delayed).
This medicine contains 0.525 mg benzyl alcohol in each 5 ml.
Ask your doctor or pharmacist for advice if you are pregnant or breast-feeding. This is because large amounts of benzyl alcohol can build-up in your body and may cause side effects (called "metabolic acidosis").
Ask your doctor or pharmacist for advice if you have liver or kidney disease. This is because large amounts of benzyl alcohol can build-up in your body and may cause side effects (called "metabolic acidosis").
A time-interval of 2 hours should be considered between Gaviscon intake and the administration of other medicinal products, especially tetracyclines, fluoroquinolones, iron salts, thyroid hormones, chloroquine, bisphosphonates, and estramustine.
Pregnancy:
Clinical studies in more than 500 pregnant women as well as a large amount of data from post-marketing experience indicate no malformative nor foeto/neonatal toxicity of the active substances. Gaviscon can be used during pregnancy, if clinically needed.
Breast feeding:
No known effect on breast fed infants. Gaviscon can be used during breast feeding.
Fertility:
No known effect on human fertility.
Adverse reactions have been ranked under headings of frequency using the following convention: very common (1/10), common (1/100 and <1/10), uncommon (1/1000 and <1/100), rare (1/10,000 and <1/1000), very rare (< 1/10,000) and not known (cannot be estimated from the available data).
System Organ Class
Frequency
Adverse Event
Gastrointestinal Disorders
Uncommon
Diarrhoea, nausea, vomiting.
Immune System Disorders
Very rare
Anaphylactic and anaphylactoid reactions. Hypersensitivity reactions such as urticaria.
Respiratory, Thoracic and Mediastinal Disorders
Very rare
Respiratory effects such as bronchospasm.
Reporting of Suspected Adverse Reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Symptoms
Symptoms are likely to be minor; some abdominal discomfort may be experienced.
Management
In the event of overdose, symptomatic treatment should be given.
Ask anything about Gaviscon Advance Aniseed flavour Oral Suspension. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.